Monday, July 14, 2025
HomeIndustriesBiotechnology

Biotechnology

Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial

Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced that the Italian Medicines Agency, or Agenzia Italiana del...

Novavax COVID-19 Vaccine Nuvaxovid Recommended for Expanded Conditional Marketing Authorization

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that the Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine has...

Meltmedia joins Evoke, Boosting Data-Driven Omnichannel and Marketing Technology Capabilities

Meltmedia, an award-winning provider of digital strategy, design, and development services to the life science industry, has been acquired by Evoke, a global brand,...

RegeneRx Licensee to Expand Phase 3 Clinical Trial Program with RGN-259

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting that its U.S. joint venture (JV) partner...

Boehringer Ingelheim Canada Partners with Plug and Play Alberta to Advance Digital Health Innovation

Plug and Play Tech Center, a global innovation platform, announced a new partnership with Boehringer Ingelheim (Canada) Ltd., a leading research-driven biopharmaceutical company. Boehringer-Ingelheim...
0FansLike
0FollowersFollow
spot_img

Hot Topics